Cardiovascular

Hyperbaric Oxygen Therapy for Diabetic Lower-Limb Wounds in the Caribbean: A Retrospective Cohort Study.

TL;DR

In this retrospective cohort of diabetic patients receiving HBOT as largely a last resort in Guadeloupe, the six-month healing rate was 34% and major amputation rate was 19%, with no candidate factor reaching statistical significance, though findings are 'consistent with a role for HBOT within coordinated multidisciplinary diabetic foot care.'

Key Findings

The six-month healing rate among evaluable diabetic patients receiving HBOT was 34%.

  • 18 out of 53 evaluable patients achieved healing at six months.
  • 257 total patients received HBOT at the center; 71 diabetic patients met inclusion criteria.
  • Mean age was 63.1 ± 12.7 years; 69% were male.
  • HBOT was administered at 2.5 ATA with 100% oxygen.
  • The study period was January 2020 to June 2023 at the only hyperbaric center in Guadeloupe.

The major amputation rate during or after HBOT was 19%.

  • 19% of the 71 included diabetic patients underwent major amputation during or after the HBOT course.
  • Peripheral arterial disease and osteitis were described as highly prevalent in this cohort.
  • HBOT was considered a last resort after failure of prolonged conventional therapy in 63% of patients.
  • The authors noted this last-resort usage likely contributed to the modest healing and amputation outcomes.

HBOT was used as a last resort after failure of prolonged conventional therapy in the majority of patients.

  • 63% of patients were referred to HBOT only after conventional therapy had failed.
  • The authors describe this as 'likely contributing to the modest six-month healing rate of 34% and 19% rate of major amputation.'
  • The study was conducted at the only hyperbaric center in Guadeloupe, a French Caribbean territory.
  • This pattern of late referral is identified as a key contextual factor shaping outcomes.

The proportion of current smokers (7.9%) was notably lower than in previously published HBOT cohorts.

  • Current smoker prevalence was 7.9% in this cohort.
  • The authors describe this as 'a distinctive feature of this population' compared to other published HBOT cohorts.
  • Peripheral arterial disease and osteitis were highly prevalent, indicating substantial comorbidity burden despite low smoking rates.

Patients referred through the multidisciplinary Diabetic Foot Care Unit had fewer major amputations despite older age and greater vascular burden.

  • The difference in major amputation rates between referral pathways was observed but not statistically significant.
  • Patients from the multidisciplinary unit were described as older with greater vascular burden.
  • The authors cautioned that 'this comparison may reflect referral-related selection bias.'
  • No candidate factor, including glycemic control, referral pathway, or delay to HBOT, reached statistical significance in univariable analysis.

No candidate factor examined reached statistical significance in univariable analysis.

  • Factors tested included glycemic control, referral pathway, and delay to HBOT initiation.
  • None of these variables were significantly associated with outcomes.
  • The authors attributed this in part to the small sample size (71 included patients).
  • The study is described as 'descriptive, single-arm' and explicitly stated it 'cannot establish HBOT efficacy.'

What This Means

This research studied 71 diabetic patients in Guadeloupe (a French Caribbean island) who received hyperbaric oxygen therapy (HBOT) — a treatment where patients breathe pure oxygen under increased pressure — for serious lower-limb wounds between 2020 and 2023. The study found that only about one-third of patients (34%) had their wounds healed within six months, and nearly one in five (19%) required a major amputation during or after treatment. Notably, in nearly two-thirds of cases, HBOT was only tried after other treatments had already failed over a long period, which the researchers believe contributed to these relatively modest outcomes. The study also found that patients who were referred through a specialized multidisciplinary diabetic foot care team seemed to have fewer major amputations, even though they tended to be older and have more severe vascular disease. However, the researchers caution this difference may simply reflect which types of patients were sent to that team rather than a true benefit of the referral pathway. No specific patient characteristics — including blood sugar control, how they were referred, or how long they waited for HBOT — were statistically linked to better or worse outcomes, partly because the study group was relatively small. This research suggests that HBOT may play a supportive role when integrated into coordinated, team-based diabetic foot care, and that referring patients to HBOT earlier — rather than as a last resort — might improve results. Because this was a single-center observational study without a control group, it cannot prove that HBOT itself caused any of the outcomes observed, and the findings are meant to inform future research and care organization rather than provide definitive treatment guidance.

Have a question about this study?

Citation

Chingan Martino V, Pusel M, Bouamama D, Gibert D, Cheret A. (2026). Hyperbaric Oxygen Therapy for Diabetic Lower-Limb Wounds in the Caribbean: A Retrospective Cohort Study.. International wound journal. https://doi.org/10.1111/iwj.71040